Literature DB >> 20962641

Cognition and behaviour in motor neurone disease.

Patricia Lillo1, John R Hodges.   

Abstract

PURPOSE OF REVIEW: Motor neurone disease has traditionally been considered a pure motor syndrome which spares aspects of cognition and behaviour, although in recent years it has been suggested that up to 50% of patients with motor neurone disease may develop frontal dysfunction which, in some cases, is severe enough to reach criteria for frontotemporal dementia. We review the cognitive and behavioural changes in motor neurone disease emphasizing the recent advances. RECENT
FINDINGS: A major advance in pathology has been the recent discovery of TDP-43 and FUS inclusions as the key components in cases of motor neurone disease, frontotemporal dementia-motor neurone disease and some cases with pure frontotemporal dementia. In addition, mutations in TARDBP and FUS genes have been reported in recent years. Longitudinal studies showed that progression of cognitive impairment over the course of motor neurone disease appears to be mild and occurs only in a proportion of motor neurone disease patients. The presence of cognitive impairment seems to be related to a faster disease and a shorter survival.
SUMMARY: Motor neurone disease is a multi-system disorder which overlaps with frontotemporal dementia. Behavioural and cognitive changes appear to occur in a subset of patients with motor neurone disease, but the cause of this variability remains unclear.

Entities:  

Mesh:

Year:  2010        PMID: 20962641     DOI: 10.1097/WCO.0b013e3283400b41

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  4 in total

1.  Cognitive impairment, behavioral impairment, depression, and wish to die in an ALS cohort.

Authors:  Judith Rabkin; Raymond Goetz; Jennifer Mary Murphy; Pam Factor-Litvak; Hiroshi Mitsumoto
Journal:  Neurology       Date:  2016-08-05       Impact factor: 9.910

2.  Cognitive-behavioral screening reveals prevalent impairment in a large multicenter ALS cohort.

Authors:  Jennifer Murphy; Pam Factor-Litvak; Raymond Goetz; Catherine Lomen-Hoerth; Peter L Nagy; Jonathan Hupf; Jessica Singleton; Susan Woolley; Howard Andrews; Daragh Heitzman; Richard S Bedlack; Jonathan S Katz; Richard J Barohn; Eric J Sorenson; Björn Oskarsson; J Americo M Fernandes Filho; Edward J Kasarskis; Tahseen Mozaffar; Yvonne D Rollins; Sharon P Nations; Andrea J Swenson; Boguslawa A Koczon-Jaremko; Hiroshi Mitsumoto
Journal:  Neurology       Date:  2016-01-22       Impact factor: 9.910

3.  Deletion of the endogenous TrkB.T1 receptor isoform restores the number of hippocampal CA1 parvalbumin-positive neurons and rescues long-term potentiation in pre-symptomatic mSOD1(G93A) ALS mice.

Authors:  Eros Quarta; Gianluca Fulgenzi; Riccardo Bravi; Erez James Cohen; Sudhirkumar Yanpallewar; Lino Tessarollo; Diego Minciacchi
Journal:  Mol Cell Neurosci       Date:  2018-03-24       Impact factor: 4.314

4.  Executive Dysfunctions and Event-Related Brain Potentials in Patients with Amyotrophic Lateral Sclerosis.

Authors:  Caroline Seer; Stefanie Fürkötter; Maj-Britt Vogts; Florian Lange; Susanne Abdulla; Reinhard Dengler; Susanne Petri; Bruno Kopp
Journal:  Front Aging Neurosci       Date:  2015-12-18       Impact factor: 5.750

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.